Mutual of America Capital Management’s Fortress Biotech FBIO Stock Holding History

Mutual of America Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-9,587	Closed	-$285K	–	1262
2014 Q1	$285K	Sell	9,587 -15,481	-62%	-$604K	0.01%	1155
2013 Q4	$989K	Buy	25,068 +12,220	+95%	+$472K	0.02%	971
2013 Q3	$1.35M	Buy	12,848 +6,232	+94%	+$764K	0.04%	818
2013 Q2	$853K	Buy	+6,616	New	+$975K	0.03%	945

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mutual of America Capital Management's FBIO Position: Q2 2014 in Review

Mutual of America Capital Management sold out of Fortress Biotech (FBIO) in Q2 2014, closing a stake of 9,587 shares — an estimated $285K sold.

Mutual of America Capital Management first reported a position in FBIO in Q2 2013 and held it in 4 quarters. The position peaked at $1.35M in Q3 2013. 48 funds tracked by Wall St. Rank hold FBIO as of Q2 2014.

Mutual of America Capital Management reported no remaining Fortress Biotech position as of Q2 2014 after selling out during the quarter.
Mutual of America Capital Management sold 9,587 Fortress Biotech shares in Q2 2014, an estimated $285K.
Mutual of America Capital Management first reported a position in Fortress Biotech in Q2 2013 and held it in 4 quarters.
Mutual of America Capital Management's Fortress Biotech position peaked at $1.35M in Q3 2013.
48 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2014.

Based on Mutual of America Capital Management's 13F filing for Q2 2014, filed 7 Aug 2014.